GLUE – monte rosa therapeutics, inc. (US:NASDAQ)
Stock Stats
News
NLRP3 Protein Inhibitors Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight | DelveInsight [Yahoo! Finance]
Monte Rosa Therapeutics to Participate in the Jefferies London Healthcare Conference
Owning 47% shares,institutional owners seem interested in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE), [Yahoo! Finance]
Monte Rosa Therapeutics (GLUE) Reports Q3 Loss, Tops Revenue Estimates [Yahoo! Finance]
Monte Rosa Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update
Form SC 13G/A Monte Rosa Therapeutics, Filed by: PRICE T ROWE ASSOCIATES INC /MD/
Form SC 13G/A Monte Rosa Therapeutics, Filed by: FMR LLC
Form 10-Q Monte Rosa Therapeutics, For: Sep 30
Form 8-K Monte Rosa Therapeutics, For: Nov 07
Form SC 13D/A Monte Rosa Therapeutics, Filed by: Versant Venture Capital VI, L.P.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.